Autonomic dysfunction as manifestation of ICANS: A case report
[Rationale]: Anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy is a successful treatment for B-cell malignancies associated with cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Cardiovascular toxicities have also been reported in this sett...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/387555 |
| Acceso en línea: | http://hdl.handle.net/10261/387555 |
| Access Level: | acceso abierto |
| Palabra clave: | Chimeric antigen receptor T cells-dysautonomia Diffuse large B-cell lymphoma ICANS Neurotoxicity Tachycardia |
| id |
ES_d264bd9faa0c29559bb7231a540d7047 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/387555 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Autonomic dysfunction as manifestation of ICANS: A case reportRochate, DinaGonzález-García, Antonio ManuelMarcos Santos, CarmenPérez-López, EstefaníaMartín López, Ana ÁfricaAlaña, MónicaMartín-Martín, LourdesLópez-Parra, MiriamSánchez-Guijo, Fermín M.López-Corral, LucíaChimeric antigen receptor T cells-dysautonomiaDiffuse large B-cell lymphomaICANSNeurotoxicityTachycardia[Rationale]: Anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy is a successful treatment for B-cell malignancies associated with cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Cardiovascular toxicities have also been reported in this setting. However, there is scarce data regarding development of autonomic disorders after CAR-T cell therapy.[Patient concerns]: We report a case with a patient with non-Hodgkin B-cell lymphoma, refractory to 2 prior lines of immunochemotherapy, treated with CAR-T therapy.[Diagnoses]: Orthostatic hypotension secondary to autonomic dysfunction was diagnosed as manifestation of ICANS.[Interventions]: The patient received metilprednisolone 1000 mg IV daily for 3 days and anakinra 100 mg IV every 6h.[Outcomes]: The vast majority of autonomic symptoms ceased and 4 months after CAR-T therapy, autonomic dysfunction was resolved.[Lessons]: New-onset autonomic dysfunction can occur as manifestation of ICANS in patients who experience persistent neurologic and cardiovascular symptoms after resolution of acute neurotoxicity and should be early recognized. Differences in differential diagnosis, mechanisms and treatment approaches are discussed.Peer reviewedLippincott Williams & WilkinsConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202520252024info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/387555reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/10.1097/MD.0000000000038659Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3875552026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Autonomic dysfunction as manifestation of ICANS: A case report |
| title |
Autonomic dysfunction as manifestation of ICANS: A case report |
| spellingShingle |
Autonomic dysfunction as manifestation of ICANS: A case report Rochate, Dina Chimeric antigen receptor T cells-dysautonomia Diffuse large B-cell lymphoma ICANS Neurotoxicity Tachycardia |
| title_short |
Autonomic dysfunction as manifestation of ICANS: A case report |
| title_full |
Autonomic dysfunction as manifestation of ICANS: A case report |
| title_fullStr |
Autonomic dysfunction as manifestation of ICANS: A case report |
| title_full_unstemmed |
Autonomic dysfunction as manifestation of ICANS: A case report |
| title_sort |
Autonomic dysfunction as manifestation of ICANS: A case report |
| dc.creator.none.fl_str_mv |
Rochate, Dina González-García, Antonio Manuel Marcos Santos, Carmen Pérez-López, Estefanía Martín López, Ana África Alaña, Mónica Martín-Martín, Lourdes López-Parra, Miriam Sánchez-Guijo, Fermín M. López-Corral, Lucía |
| author |
Rochate, Dina |
| author_facet |
Rochate, Dina González-García, Antonio Manuel Marcos Santos, Carmen Pérez-López, Estefanía Martín López, Ana África Alaña, Mónica Martín-Martín, Lourdes López-Parra, Miriam Sánchez-Guijo, Fermín M. López-Corral, Lucía |
| author_role |
author |
| author2 |
González-García, Antonio Manuel Marcos Santos, Carmen Pérez-López, Estefanía Martín López, Ana África Alaña, Mónica Martín-Martín, Lourdes López-Parra, Miriam Sánchez-Guijo, Fermín M. López-Corral, Lucía |
| author2_role |
author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Chimeric antigen receptor T cells-dysautonomia Diffuse large B-cell lymphoma ICANS Neurotoxicity Tachycardia |
| topic |
Chimeric antigen receptor T cells-dysautonomia Diffuse large B-cell lymphoma ICANS Neurotoxicity Tachycardia |
| description |
[Rationale]: Anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy is a successful treatment for B-cell malignancies associated with cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Cardiovascular toxicities have also been reported in this setting. However, there is scarce data regarding development of autonomic disorders after CAR-T cell therapy. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/387555 |
| url |
http://hdl.handle.net/10261/387555 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://dx.doi.org/10.1097/MD.0000000000038659 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Lippincott Williams & Wilkins |
| publisher.none.fl_str_mv |
Lippincott Williams & Wilkins |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869420368876273664 |
| score |
15,812429 |